Novobind Revenue and Competitors
Estimated Revenue & Valuation
- Novobind's estimated annual revenue is currently $2.5M per year.
- Novobind's estimated revenue per employee is $155,000
Employee Data
- Novobind has 16 Employees.
- Novobind grew their employee count by -6% last year.
Novobind's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder and CEO | Reveal Email/Phone |
2 | Scientist - Contractor/Consultant | Reveal Email/Phone |
3 | Scientist | Reveal Email/Phone |
4 | Scientist | Reveal Email/Phone |
5 | Consultant | Reveal Email/Phone |
Novobind Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.1M | 40 | 18% | $40M | N/A |
#2 | $0.2M | 2 | 0% | N/A | N/A |
#3 | $1.3M | 17 | -15% | N/A | N/A |
#4 | $2.6M | 17 | 6% | N/A | N/A |
#5 | $12.9M | 83 | 5% | N/A | N/A |
#6 | $1.9M | 24 | 4% | $89.5M | N/A |
#7 | $2.8M | 18 | 6% | N/A | N/A |
#8 | $40.3M | 260 | 21% | N/A | N/A |
#9 | $0.9M | 6 | 0% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is Novobind?
NovoBind is an integrated animal health company utilizing next-generation biologics to target and neutralize key pathogens affecting producers and food safety. We target pathogens that cause >$1B of production losses and have been materially affected by the following: 1) Antibacterial resistance, 2) A Regulatory ban on antibiotics, and; 3) Changing consumer sentiment.
keywords:N/AN/A
Total Funding
16
Number of Employees
$2.5M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | N/A | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $1.4M | 16 | N/A | N/A |
#4 | $2.6M | 16 | N/A | N/A |
#5 | $1.4M | 16 | N/A | N/A |